Cohort · OBS-LIVER-F4407Active studySynthetic mock data
Cirrhotic surveillance — high-risk
Owner RP · last updated 2026-03-30
Size
219
Status
locked
Inclusion criteria
2
Exclusion criteria
1
Definition
Inclusion
- +Compensated cirrhosis (any etiology)
- +Prior nodule on US within 24 mo
Exclusion
- −Active HCC at enrollment
lockedOBS-LIVER-F4407Owner RPLast updated 2026-03-30
Enrollment over time
From wk 0 (n=0) to wk 48 (n=219)
Subjects in cohort (12)
| Subject | MRN | Age / Sex | Site | Enrolled | Status |
|---|---|---|---|---|---|
| LIV-HR-001 Maria Alvarez | MRN 6026500 | 48 / F | Site 03 — Chicago | 2024-04-08 | withdrawn |
| LIV-HR-002 Henry Müller | MRN 6026501 | 51 / M | Site 09 — Munich | 2024-04-13 | active |
| LIV-HR-003 Rachel Sørensen | MRN 6026502 | 54 / F | Site 12 — Singapore | 2024-04-18 | active |
| LIV-HR-004 Robert Adebayo | MRN 6026503 | 57 / M | Site 14 — Boston | 2024-04-23 | active |
| LIV-HR-005 Priya Iversen | MRN 6026504 | 60 / F | Site 18 — Toronto | 2024-04-28 | active |
| LIV-HR-006 Theo O'Connor | MRN 6026505 | 63 / M | Site 22 — Madrid | 2024-05-03 | active |
| LIV-HR-007 Sara Tanaka | MRN 6026506 | 66 / F | Site 03 — Chicago | 2024-05-08 | active |
| LIV-HR-008 Antonio Marquez | MRN 6026507 | 69 / M | Site 09 — Munich | 2024-05-13 | active |
| LIV-HR-009 Aisha Hassan | MRN 6026508 | 72 / F | Site 12 — Singapore | 2024-05-18 | active |
| LIV-HR-010 Omar Singh | MRN 6026509 | 75 / M | Site 14 — Boston | 2024-05-23 | active |
| LIV-HR-011 Fatima Patel | MRN 6026510 | 48 / F | Site 18 — Toronto | 2024-05-28 | active |
| LIV-HR-012 David Garcia | MRN 6026511 | 51 / M | Site 22 — Madrid | 2024-06-02 | completed |
Linked study
OBS-LIVER-F4407
Multi-modality surveillance of cirrhotic cohort
Time-to-HCC detection · 612/800 enrolled
Sister cohorts in OBS-LIVER-F4407
Endpoints attached to this protocol
Cross-links